General Information of the Compound
Compound ID
CP0545538
Compound Name
[(1R)-2-(1-benzofuran-3-yl)-1-[[(1S,2R,4R)-7-oxabicyclo[2.2.1]heptane-2-carbonyl]amino]ethyl]boronic acid
    Show/Hide
Synonyms
((R)-2-(Benzofuran-3-yl)-1-((1S,2R,4R)-7-oxabicyclo[2.2.1]heptane-2-carboxamido)ethyl)boronic acid
2285330-15-4
CS-0091883
HY-111790
LMP7-IN-1
M3258
NSC-818432
NSC818432
    Show/Hide
Structure
Formula
C17H20BNO5
Molecular Weight
329.161
Canonical SMILES
OB(O)[C@H](Cc1coc2ccccc12)NC(=O)[C@@H]1C[C@H]2CC[C@@H]1O2
    Show/Hide
InChI
InChI=1S/C17H20BNO5/c20-17(13-8-11-5-6-15(13)24-11)19-16(18(21)22)7-10-9-23-14-4-2-1-3-12(10)14/h1-4,9,11,13,15-16,21-22H,5-8H2,(H,19,20)/t11-,13-,15+,16+/m1/s1
    Show/Hide
InChIKey
RFQDLTYXNINJON-OYNZBZHQSA-N
Physicochemical Property
logP
1.0396
Rotatable Bonds
5
Heavy Atom Count
24
Polar Areas
91.93
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
5
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 138319683
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02585, Proteasome subunit beta type-5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000068 A-549 Homo sapiens (Human)  1
1
IC50 = 1035 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 2500 nM
Protein ID: PT03168, Proteasome subunit beta type-8
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000752 PBMC iPSC #1 Homo sapiens (Human)  1
1
IC50 = 3.4 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 3.6 nM
Clinical Information about the Compound
Drug 1 ( M3258 )
Drug Name M3258
Company EMD Serono
Indication
Multiple myeloma
Phase 1
Target(s)
Proteasome beta-8 (PS beta-8)
Inhibitor